北大医药第三季度营收、净利双降

Core Insights - The company reported a revenue of approximately 1.23 billion yuan for the first three quarters of 2025, representing a year-on-year decline of 19.76% [1] - The net profit attributable to shareholders for the same period was 136 million yuan, showing a year-on-year increase of 4.31% [1] - In the third quarter, the company achieved a revenue of about 274 million yuan, which is a significant year-on-year decrease of 47.95% [1] - The net profit for the third quarter was approximately 35.7 million yuan, reflecting a year-on-year decline of 18.04% [1]